Tag Archives: Hélène Cabanas

Treatment research: …restoration using Naltrexone in natural killer cells of ME/CFS patients

Posted on 02/23/2022 by wames

Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients, by Natalie Eaton-Fitch, Stanley Du Preez, Hélène Cabanas, Katsuhiko Muraki, Donald Staines & Sonya Marshall-Gradisnik in Journal of Translational Medicine volume 20, … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Treatment research: …restoration using Naltrexone in natural killer cells of ME/CFS patients

Research: The characterization of IL-2 stimulation & treatment of TRPM3… in ME/CFS

Posted on 11/15/2021 by wames

Characterization of IL-2 stimulation and TRPM7 pharmacomodulation in NK Cell cytotoxicity and channel Co-Localization with PIP2 in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome patients, by Stanley Du Preez , Natalie Eaton-Fitch, Helene Cabanas, Donald Staines and Sonya Marshall-Gradisnik in Int. J. … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: The characterization of IL-2 stimulation & treatment of TRPM3… in ME/CFS

Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS

Posted on 07/16/2021 by wames

Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: role of Transient Receptor Potential Melastatin 3 Ion channels in pathophysiology and treatment, by Helene Cabanas,  Katsuhiko Muraki,  Natalie Eaton-Fitch,  Donald Ross Staines and Sonya Marshall-Gradisnik in … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS

Systematic review of sleep characteristics in ME/CFS

Posted on 06/15/2021 by wames

Systematic review of sleep characteristics in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome, by  Rebekah Maksoud, Natalie Eaton-Fitch, Michael Matula, Hélène Cabanas, Donald Staines and Sonya Marshall-Gradisnik in Healthcare 2021, 9(5), 568; 11 May 2021  [doi.org/10.3390/healthcare9050568] (This article belongs to the Special Issue ME/CFS … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Systematic review of sleep characteristics in ME/CFS

A systematic review of nutraceutical interventions for mitochondrial dysfunctions in ME/CFS

Posted on 03/03/2021 by wames

A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome, by  in Journal of Translational Medicine vol 19, no.: 81 (2021)   Review abstract: Background Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating illness, characterised by … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on A systematic review of nutraceutical interventions for mitochondrial dysfunctions in ME/CFS

A systematic review of mitochondrial abnormalities in ME/CFS/SEID

Posted on 08/16/2020 by wames

A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease, by Sean Holden, Rebekah  Maksoud, Natalie Eaton-Fitch, Hélène Cabanas, Donald Staines & Sonya Marshall-Gradisnik in Journal of Translational Medicine vol 18, no: 290 (2020)[doi.org/10.1186/s12967-020-02452-3]   Review … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on A systematic review of mitochondrial abnormalities in ME/CFS/SEID

A systematic review of neurological impairments in ME/CFS using neuroimaging techniques

Posted on 05/04/2020 by wames

A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques, by Rebekah Maksoud, Stanley du Preez, Natalie Eaton-Fitch, Kiran Thapaliya, Leighton Barnden, Hélène Cabanas, Donald Staines, Sonya Marshall-Gradisnik in PLoS One 2020 Apr 30;15(4) [doi:10.1371/journal.pone.0232475.   … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on A systematic review of neurological impairments in ME/CFS using neuroimaging techniques

Transient receptor potential melastatin 2 channels are overexpressed in ME/CFS patients

Posted on 12/18/2019 by wames

Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients, by Cassandra Balinas, Helene Cabanas, Donald Staines, Sonya Marshall-Gradisnik in Journal of Translational Medicine Vol 17, #1, p 401, December 3, 2019   Research abstract: Background: Myalgic … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Transient receptor potential melastatin 2 channels are overexpressed in ME/CFS patients

A systematic review of natural killer cells profile & cytotoxic function in ME/CFS

Posted on 11/21/2019 by wames

A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome, by Natalie Eaton-Fitch, Stanley du Preez, Hélène Cabanas, Donald Staines & Sonya Marshall-Gradisnik in Systematic Reviews vol 8, no: 279 (2019)   Review abstract: … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on A systematic review of natural killer cells profile & cytotoxic function in ME/CFS

Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from ME/CFS

Posted on 10/31/2019 by wames

Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients, by Helene Cabanas,  Katsuhiko Muraki,  Donald Staines and Sonya Marshall-Gradisnik in Front. Immunol., 31 October 2019 [https://doi.org/10.3389/fimmu.2019.02545]   Research … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from ME/CFS